Multiple Missense Mutations in the Diazepam Binding Inhibitor (DBI) Gene Identified in Schizophrenia but Lack of Disease Association

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 125 B, Issue 1, 2004, Pages 10-19

  Niu, N ^a   Rice, S R ^a   Heston, L L ^b   Sobell, J L ^a,c  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Acyl CoA binding protein; Association study; Gabaergic neurotransmission; Mitochondrial (peripheral) benzodiazepine receptor; Mutation scan; Nucleotide diversity

Indexed keywords

4 AMINOBUTYRIC ACID; ACYL COENZYME A BINDING PROTEIN; BENZODIAZEPINE RECEPTOR; BINDING PROTEIN; DIAZEPAM BINDING INHIBITOR; POLYPEPTIDE; UNCLASSIFIED DRUG;

ANXIETY DISORDER; ARTICLE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE DELETION; GENETIC ASSOCIATION; GENETIC CONSERVATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMBRANE TRANSPORT; MISSENSE MUTATION; MOOD DISORDER; NEUROTRANSMISSION; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PSYCHOSIS; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; STEROIDOGENESIS;

EID: 0942301437     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.20102     Document Type: Article

References (38)

1. American Psychiatric Association. 1987. Diagnostic and statistical manual for psychiatric disorders, revised (DSM-III-R). Washington DC: American Psychiatric Association Press.
2. Besman MJ, Yanagibashi K, Lee TD, Kawamura M, Hall PH, Shively JE. 1989. Identification of des-(Gly-Ile)-endozepine as an effector of corticotropin-dependent adrenal steroidogenesis: Stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor. Proc Natl Acad Sci USA 86(13):4897-4901.
3. Cinone N, Hotje HD, Carotti A. 2000. Development of a unique 3D interaction model of endogenous and synthetic peripheral benzodiazepine receptor ligands. J Comput Aided Mol Des 14(8):753-768.
4. Costa E, Guidotti A. 1991. Diazepam binding inhibirot (DBI): A peptide with mulitple biological actions. Life Sci 49(5):325-344.
5. Costa E, Cheney D, Grayson D, Korneyev A, Longone P, Pani L, Romeo E, Zivkovich E, Guidotti A. 1994. Pharmacology of neurosteroid biosynthesis. Ann NY Acad Sci 746:223-242.
6. Dong E, Matsumoto K, Tohda M, Kaneko Y, Watanabe H. 1999. Diazepam binding inhibitor (DBI) gene expression in the brains of socially isolated and group-housed mice. Neurosci Res 33(3):171-177.
7. Edgar PF, Schonberger SJ, Dean B, Faull RL, Kydd R, Cooper GJ. 1999. A comparative proteome analysis of hippocampal tissue from schizophrenic and Alzheimer's disease individuals. Mol Psychiatry 4(2):173-178.
8. Ferrarese C, Mennini T, Pecora N, Pierpaoli C, Frigo M, Marzorati C, Gobbi M, Bizzi A, codegoni A, Garattini S, et al. 1991. Diazepam binding inhibitor (DBI) increases after acute stress in rat. Neuropharmacology 30(12B):1445-1452.
9. Flood JF, Morley JE, Roberts E. 1992. Memory-enhancing effects in male mice of pregnenolone and of steroids metabolically derived from it. Proc Natl Acad Sci 89(5):1567-1571.
10. Gavish M, Bachman I, Shoukrun R, Katz Y, Veenman L, Weisinger G, Weizman A. 1999. Enigma of the peripheral benzodiazepine receptor. Pharm Rev 51(4):629-650.
11. Halushka MK, Fan J-B, Bentley K, Hsie L, Shen N, Weder A, Cooper R, Lipshutz R, Chakravarti A. 1999. Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat Genet 22:239-247.
12. Joseph-Liauzun E, Farges R, Delmas P, Ferrara P, Loison G. 1997. The Mr 18,000 subunit of the peripheral-type benzodiazepine receptor exhibits both benzodiazepine and isoquinoline carboxamide binding sites in the absence of the voltage-dependent anion channel or of the adenine nucleotide carrier. J Biol Chem 272(44):28102-28106.
13. Katsura M, Hara A, Higo A, Tarumi C, Hibino Y, Ohkuma S. 1998. Continuous treatment with morphine increases diazepam binding inhibitor mRNA in mouse brain. J Neurochem 71:2638-2641.
14. Kolmer M, Alho H, Costa E, Pani L. 1993. Cloning and tissue-specific functional characterization of the promoter of the rat diazepam binding inhibitor, a peptide with multiple biological actions. Proc Natl Acad Sci 90:8439-8443.
15. Kolmer M, Rovio A, Alho H. 1995. The characterization of two diazepam binding inhibitor (DBI) transcripts in humans. Biochem J 306:327-330.
16. Korneyev A, Pan BS, Polo A, Romeo E, Guidotti A, Costa E. 1993. Stimulation of brain prenenolone synthesis by mitochondrial diazepam binding inhibitor receptor ligands in vivo. J Neurochem 61(4):1515-1524.
17. Kragelund B, Knudsen J, Poulsen F. 1999a. Acyl-coenzyme A binding protein (ACBP). Biochim Biophys Acta 1441:150-161.
18. Kragelund B, Poulsen K, Andersen K, Baldursson T, Kroll J, Neergard T, Jepsen J, Roepstorff P, Kristiansen K, Poulsen F, Knudsen J. 1999b. Conserved residues and their role in the structure, function, and stability of acyl-coenzyme A binding protein. Biochemistry 38:2386-2394.
19. Lancaster JM, Berchuck A, Futreal PA, Wiseman RW. 1997. Dideoxy fingerprinting assay for BRCA1 mutation analysis. Mol Carcinog 19(3): 176-179.
20. Larsen LA, Johnson M, Brown C, Christiansen M, Frank-Hansen R, Vuust J, Andersen PS. 2001. Automated mutation screening using dideoxy fingerprinting and capillary array electrophoresis. Hum Mut 18(5): 451-457.
21. Liu Q, Feng J, Sommer SS. 1996. Bi-directional dideoxy fingerprinting (Bi-ddF): A rapid method for quantitative detection of mutations in genomic regions of 300-600 bp. Hum Mol Genet 5(1):107-114.
22. Martincic D, Whitlock JA. 1996. Improved detection of p53 point mutations by dideoxy fingerprinting (ddF). Oncogene 13(9):2039-2044.
23. McEnery NW. 1992. The mitochondrial benzodiazepine receptor: Evidence for association with the voltage-dependent anion channel (VDAC). J Bioenerg Biomembr 24(1):63-69.
24. Mellon SH, Griffin LD. 2002. Neurosteroids: Biochemistry and clinical significance. Trends Endocrinol Metab 13(1):35-43.
25. Mortaud S, Degrelle H. 1996. Steroid control of higher brain function and behavior. Behav Genet 26(4):367-372.
26. Nickerson DA, Taylor SL, Weiss KM, Clark AG, Hutchinson RG, Stengard J, Salomaa V, Vartiainen E, Boerwinkle E, Sing CF. 1998. DNA sequence diversity in a 9.7 kb region of the human lipoprotein lipase gene. Nat Genet 19:233-240.
27. Reddy D, Kulkarni S. 1997. Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice. Brain Res 752:61-71.
28. Rice SR, Niu N, Berman DB, Heston LL, Sobell JL. 2001. Identification of single nucleotide polymorphisms (SNPs) and other sequence changes and estimation of nucleotide diversity in coding and flanking regions of the NMDAR1 receptor gene in schizophrenic patients. Mol Psychiatry 6:274-284.
29. Rupprecht R, Holsboer F. 1999. Neuropsychopharmacological properties of neuroactive steroids. Steroids 64:83-91.
30. Slobodyansky E, Guidotti A, Wambebe C, Berkovich A, Costa E. 1989. Isolation and characterization of a rat brain triakontatetraneuropeptide, a posttranslational product of diazepam binding inhibitor: Specific action at the Ro 5-4864 recognition site. J Neurochem 53(4):1276-1284.
31. Sobell J, Heston L, Sommer S. 1993. Novel association approach for determining the genetic predisposition to schizophrenia: Case-control resource and testing of a candidate gene. Am J Med Genet (Neuropsychol Genet) 48(1):28-35.
32. Stoffel-Wagner B. 2001. Neurosteroid metabolism in the human brain. Eur J Endocr 145:669-679.
33. Swinnen J, Esquenet M, Rosseels J, Claessens F, Rombauts W, Heyns W, Verhoeven G. 1996. A human gene encoding diazepam-binding inhibitor/acyl-CoA-binding protein: Transcription and hormonal regulation in the androgen-sensitive human prostatic adenocarcinoma cell line LNCaP. DNA Cell Biol 15:197-208.
34. Swinnen J, Alen P, Heyns W, Verhoeven G. 1998. Identification of diazepam-binding inhibitor/acyl-CoA-binding protein as a sterol regulatory element-binding protein-responsive gene. J Biol Chem 273(32):19938-19944.
35. Teilum K, Maki K, Kragelund BB, Poulsen FM, Roder H. 2002. Early kinetic intermediate in the folding of acyl-CoA binding protein detected by fluorescence labeling and ultrarapid mixing. Proc Natl Acad Sci 99(15):9807-9812.
36. van Kammen DP, Guidotti A, Kelley ME, Gurklis J, Guarneri P, Gilbertson MW, Yao JK, Peters J, Costa E. 1993. CSF diazepam binding inhibitor and schizophrenia: Clinical and biochemical relationships. Biol Psychiatry 34(8):515-522.
37. Webb NR, Rose TM, Malik N, Marquardt H, Shoyab M, Todaro GJ, Lee DC. 1987. Bovine and human cDNA sequences encoding a putative benzodiazepine receptor ligand. DNA 6(1):71-79.
38. Wodarz N, Rothenhofer C, Fischer R, Stober G, Kiehl B, Jungkunz G, Riederer P, Klein HE. 1998. Peripheral-type benzodiazepine receptors in diagnostic subtypes of schizophrenic patients. Psychiatry Res 81(3): 363-369.